Evolving trends and clinical-pathological correlations in renal cell carcinoma surgery: a decade-long study at Peking University First Hospital
- PMID: 40828298
- PMCID: PMC12364738
- DOI: 10.1007/s10238-025-01770-4
Evolving trends and clinical-pathological correlations in renal cell carcinoma surgery: a decade-long study at Peking University First Hospital
Abstract
This study aimed to comprehensively delineate the clinical characteristics, surgical interventions, and evolving trends over the past decade among patients undergoing surgery for renal cell carcinoma (RCC). A retrospective analysis was conducted on the clinical records of 9,110 patients diagnosed with RCC who underwent surgical treatment at Peking University First Hospital between January 2013 and December 2022. Statistical analyses were performed using SPSS 21.0 software. Categorical variables were analyzed using the Chi-square test or Fisher's exact test, as appropriate. Numerical variables were assessed using the t-test or analysis of variance (ANOVA) for normally distributed data, while nonparametric tests were employed for non-normally distributed numerical variables or ordinal data. A p-value of less than 0.05 was considered statistically significant. The study cohort consisted of 6,416 males (70.4%) and 2,694 females (29.6%), with a median age of 55 years. Clear cell renal cell carcinoma (ccRCC) was the most prevalent histological subtype (87.6%), followed by chromophobe renal cell carcinoma (chRCC) (5.1%), papillary renal cell carcinoma (pRCC) (3.7%), and other subtypes (3.6%). Non-ccRCC patients exhibited a significantly higher proportion of advanced T3 + disease staging (19.4% vs. 15%, P < 0.001). Female patients demonstrated higher incidences of both non-ccRCC and special pathology types (P < 0.001), while non-ccRCC and advanced T-stage disease were more common in pediatric patients (P < 0.001) and were more likely to undergo radical nephrectomy (P < 0.001). Over the span of a decade, the demographic characteristics of RCC patients remained relatively stable; however, there was a notable decrease in tumor size over time (P < 0.001). Notably, partial nephrectomy rates surged between 2013 and 2016-reflecting growing acceptance of nephron-sparing techniques-but later balanced with radical nephrectomies as stricter selection criteria emerged, highlighting the dynamic evolution of RCC surgical management. Our study reveals dynamic shifts in RCC management over the past decade, marked by evolving surgical practices and a trend toward smaller tumor sizes at diagnosis, while distinct clinical features in pediatric patients underscore the need for continued refinement of early detection.
Keywords: Renal cell carcinoma; Surgery; Pathology; Decade-long study.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests.
Figures









Similar articles
-
[Clinicopathological features and survival analysis of TFE3-rearranged renal cell carcinoma with venous tumor thrombus].Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Aug 18;57(4):650-661. doi: 10.19723/j.issn.1671-167X.2025.04.004. Beijing Da Xue Xue Bao Yi Xue Ban. 2025. PMID: 40754899 Free PMC article. Chinese.
-
[A retrospective matching study of partial nephrectomy and radical nephrectomy for pathological T3a stage renal cell carcinoma].Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Aug 18;57(4):704-710. doi: 10.19723/j.issn.1671-167X.2025.04.012. Beijing Da Xue Xue Bao Yi Xue Ban. 2025. PMID: 40754907 Free PMC article. Chinese.
-
Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.Eur Urol. 2017 Apr;71(4):606-617. doi: 10.1016/j.eururo.2016.08.060. Epub 2016 Sep 7. Eur Urol. 2017. PMID: 27614693
-
Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.J Cancer Res Clin Oncol. 2017 Sep;143(9):1845-1851. doi: 10.1007/s00432-017-2430-6. Epub 2017 Apr 27. J Cancer Res Clin Oncol. 2017. PMID: 28451753 Free PMC article.
-
Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer.Eur Urol. 2012 Dec;62(6):1097-117. doi: 10.1016/j.eururo.2012.07.028. Epub 2012 Jul 20. Eur Urol. 2012. PMID: 22841673
References
-
- Siegel RL, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48. - PubMed
-
- Centers for Disease Control and Prevention. Male Urologic Cancers. USCS Data Brief, no 21. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2020.
-
- Barata PC, Rini BI. Treatment of renal cell carcinoma: current status and future directions. CA Cancer J Clin. 2017;67(6):507–24. - PubMed
-
- Amin MB, E.S., Greene FL, et al, AJCC Cancer Staging Manual. 8th ed. New York: Springer, 2017.
MeSH terms
Grants and funding
- 2024-4-40710/Capital's Funds for Health Improvement and Research
- 2022CR15/National High-Level Hospital Clinical Research Funding (Interdepartmental Clinical Research Project of Peking University First Hospital)
- 2023HQ11/National High Level Hospital Clinical Research Funding (High Quality Clinical Research Project of Peking University First Hospital)
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous